Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification

Marieke E. Ijsselsteijn, Thomas P. Brouwer, Ziena Abdulrahman, Eileen Reidy, Ana Ramalheiro, A. Marijne Heeren, Alexander Vahrmeijer, Ekaterina S. Jordanova, Noel Fcc de Miranda

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Checkpoint blockade immunotherapies have revolutionised cancer treatment in the last decade. Nevertheless, these are only beneficial for a small proportion of cancer patients. Important prognosticators for response to immunotherapy are the mutation burden of tumours as well as the quality and quantity of tumour-infiltrating immune cells. High-throughput multiplex immunophenotyping technologies have a central role in deciphering the complexity of anti-tumour immune responses. Current techniques for the immunophenotyping of solid tumours are held back by the lack of spatial context, limitations in the number of targets that can be visualised simultaneously, and/or cumbersome protocols. We developed a tyramide signal amplification-free method for the simultaneous detection of seven cellular targets by immunofluorescence. This method overcomes limitations posed by most widespread techniques and provides a unique tool for extensive phenotyping by multispectral fluorescence microscopy. Furthermore, it can be easily implemented as a high-throughput technology for validation of discovery sets generated by RNA sequencing or mass cytometry and may serve in the future as a complementary diagnostic tool.
Original languageEnglish
Pages (from-to)3-11
JournalThe journal of pathology. Clinical research
Volume5
Issue number1
DOIs
Publication statusPublished - 1 Jan 2019

Cite this

Ijsselsteijn, M. E., Brouwer, T. P., Abdulrahman, Z., Reidy, E., Ramalheiro, A., Heeren, A. M., ... de Miranda, N. F. (2019). Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification. The journal of pathology. Clinical research, 5(1), 3-11. https://doi.org/10.1002/cjp2.113
Ijsselsteijn, Marieke E. ; Brouwer, Thomas P. ; Abdulrahman, Ziena ; Reidy, Eileen ; Ramalheiro, Ana ; Heeren, A. Marijne ; Vahrmeijer, Alexander ; Jordanova, Ekaterina S. ; de Miranda, Noel Fcc. / Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification. In: The journal of pathology. Clinical research. 2019 ; Vol. 5, No. 1. pp. 3-11.
@article{0b21168886894d43956e2c5369540d6f,
title = "Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification",
abstract = "Checkpoint blockade immunotherapies have revolutionised cancer treatment in the last decade. Nevertheless, these are only beneficial for a small proportion of cancer patients. Important prognosticators for response to immunotherapy are the mutation burden of tumours as well as the quality and quantity of tumour-infiltrating immune cells. High-throughput multiplex immunophenotyping technologies have a central role in deciphering the complexity of anti-tumour immune responses. Current techniques for the immunophenotyping of solid tumours are held back by the lack of spatial context, limitations in the number of targets that can be visualised simultaneously, and/or cumbersome protocols. We developed a tyramide signal amplification-free method for the simultaneous detection of seven cellular targets by immunofluorescence. This method overcomes limitations posed by most widespread techniques and provides a unique tool for extensive phenotyping by multispectral fluorescence microscopy. Furthermore, it can be easily implemented as a high-throughput technology for validation of discovery sets generated by RNA sequencing or mass cytometry and may serve in the future as a complementary diagnostic tool.",
author = "Ijsselsteijn, {Marieke E.} and Brouwer, {Thomas P.} and Ziena Abdulrahman and Eileen Reidy and Ana Ramalheiro and Heeren, {A. Marijne} and Alexander Vahrmeijer and Jordanova, {Ekaterina S.} and {de Miranda}, {Noel Fcc}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/cjp2.113",
language = "English",
volume = "5",
pages = "3--11",
journal = "The Journal of Pathology: Clinical Research",
issn = "2056-4538",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

Ijsselsteijn, ME, Brouwer, TP, Abdulrahman, Z, Reidy, E, Ramalheiro, A, Heeren, AM, Vahrmeijer, A, Jordanova, ES & de Miranda, NF 2019, 'Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification' The journal of pathology. Clinical research, vol. 5, no. 1, pp. 3-11. https://doi.org/10.1002/cjp2.113

Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification. / Ijsselsteijn, Marieke E.; Brouwer, Thomas P.; Abdulrahman, Ziena; Reidy, Eileen; Ramalheiro, Ana; Heeren, A. Marijne; Vahrmeijer, Alexander; Jordanova, Ekaterina S.; de Miranda, Noel Fcc.

In: The journal of pathology. Clinical research, Vol. 5, No. 1, 01.01.2019, p. 3-11.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Cancer immunophenotyping by seven-colour multispectral imaging without tyramide signal amplification

AU - Ijsselsteijn, Marieke E.

AU - Brouwer, Thomas P.

AU - Abdulrahman, Ziena

AU - Reidy, Eileen

AU - Ramalheiro, Ana

AU - Heeren, A. Marijne

AU - Vahrmeijer, Alexander

AU - Jordanova, Ekaterina S.

AU - de Miranda, Noel Fcc

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Checkpoint blockade immunotherapies have revolutionised cancer treatment in the last decade. Nevertheless, these are only beneficial for a small proportion of cancer patients. Important prognosticators for response to immunotherapy are the mutation burden of tumours as well as the quality and quantity of tumour-infiltrating immune cells. High-throughput multiplex immunophenotyping technologies have a central role in deciphering the complexity of anti-tumour immune responses. Current techniques for the immunophenotyping of solid tumours are held back by the lack of spatial context, limitations in the number of targets that can be visualised simultaneously, and/or cumbersome protocols. We developed a tyramide signal amplification-free method for the simultaneous detection of seven cellular targets by immunofluorescence. This method overcomes limitations posed by most widespread techniques and provides a unique tool for extensive phenotyping by multispectral fluorescence microscopy. Furthermore, it can be easily implemented as a high-throughput technology for validation of discovery sets generated by RNA sequencing or mass cytometry and may serve in the future as a complementary diagnostic tool.

AB - Checkpoint blockade immunotherapies have revolutionised cancer treatment in the last decade. Nevertheless, these are only beneficial for a small proportion of cancer patients. Important prognosticators for response to immunotherapy are the mutation burden of tumours as well as the quality and quantity of tumour-infiltrating immune cells. High-throughput multiplex immunophenotyping technologies have a central role in deciphering the complexity of anti-tumour immune responses. Current techniques for the immunophenotyping of solid tumours are held back by the lack of spatial context, limitations in the number of targets that can be visualised simultaneously, and/or cumbersome protocols. We developed a tyramide signal amplification-free method for the simultaneous detection of seven cellular targets by immunofluorescence. This method overcomes limitations posed by most widespread techniques and provides a unique tool for extensive phenotyping by multispectral fluorescence microscopy. Furthermore, it can be easily implemented as a high-throughput technology for validation of discovery sets generated by RNA sequencing or mass cytometry and may serve in the future as a complementary diagnostic tool.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85059492750&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30191683

U2 - 10.1002/cjp2.113

DO - 10.1002/cjp2.113

M3 - Article

VL - 5

SP - 3

EP - 11

JO - The Journal of Pathology: Clinical Research

JF - The Journal of Pathology: Clinical Research

SN - 2056-4538

IS - 1

ER -